{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:17Z","timestamp":1787020757319,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of Science and Technology, Fujian province","award":["2024Y9318"],"award-info":[{"award-number":["2024Y9318"]}]},{"name":"Special Research Fund for Central Universities, Peking Union Medical College","award":["3332023098"],"award-info":[{"award-number":["3332023098"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82171777"],"award-info":[{"award-number":["82171777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Foundation of Tianjin City","award":["20JCJQJC00280"],"award-info":[{"award-number":["20JCJQJC00280"]}]},{"name":"Tianjin Health Research Project","award":["TJWJ2024RC001"],"award-info":[{"award-number":["TJWJ2024RC001"]}]},{"name":"Tianjin Public Health Science and Technology Major Project","award":["24ZXGZSY00030"],"award-info":[{"award-number":["24ZXGZSY00030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03472-w","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:19:47Z","timestamp":1749197987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis"],"prefix":"10.1186","volume":"22","author":[{"given":"Si-Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-9478","authenticated-orcid":false,"given":"Tian-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanju","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-4597","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3472_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378:169\u201380.","journal-title":"N Engl J Med"},{"key":"3472_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1474-4422(23)00459-3","volume":"23","author":"C Tur","year":"2024","unstructured":"Tur C, Tintor\u00e9 M. Multiple sclerosis in 2023: beyond the boundaries. Lancet Neurol. 2024;23:22\u20134.","journal-title":"Lancet Neurol"},{"key":"3472_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"A Bar-Or","year":"2021","unstructured":"Bar-Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol. 2021;20:470\u201383.","journal-title":"Lancet Neurol"},{"key":"3472_CR4","doi-asserted-by":"publisher","first-page":"e1906","DOI":"10.1212\/WNL.0000000000012782","volume":"97","author":"WO Tobin","year":"2021","unstructured":"Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, Tosakulwong N, Parisi JE, Metz I, Frischer JM, Lassmann H, Br\u00fcck W, et al. Clinical correlation of multiple sclerosis Immunopathologic subtypes. Neurology. 2021;97:e1906\u201313.","journal-title":"Neurology"},{"key":"3472_CR5","doi-asserted-by":"publisher","first-page":"21512","DOI":"10.1073\/pnas.2011249117","volume":"117","author":"S Kuerten","year":"2020","unstructured":"Kuerten S, Lanz TV, Lingampalli N, Lahey LJ, Kleinschnitz C, M\u00e4urer M, Schroeter M, Braune S, Ziemssen T, Ho PP, et al. Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients. Proc Natl Acad Sci U S A. 2020;117:21512\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3472_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1177\/13524585231195346","volume":"29","author":"SL Hauser","year":"2023","unstructured":"Hauser SL, Zielman R, Das Gupta A, Xi J, Stoneman D, Karlsson G, Robertson D, Cohen JA, Kappos L. Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: the ALITHIOS open-label extension. Mult Scler. 2023;29:1452\u201364.","journal-title":"Mult Scler"},{"key":"3472_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa1917246","volume":"383","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, et al. Ofatumumab versus Teriflunomide in multiple sclerosis. N Engl J Med. 2020;383:546\u201357.","journal-title":"N Engl J Med"},{"key":"3472_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, et al. Memory B cells activate Brain-Homing, autoreactive CD4\u2009<\u2009sup>+\u2009T cells in multiple sclerosis. Cell. 2018;175:85\u2013e100123.","journal-title":"Cell"},{"key":"3472_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/brain\/awx372","volume":"141","author":"I Smets","year":"2018","unstructured":"Smets I, Fiddes B, Garcia-Perez JE, He D, Mallants K, Liao W, Dooley J, Wang G, Humblet-Baron S, Dubois B, et al. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells. Brain. 2018;141:786\u201396.","journal-title":"Brain"},{"key":"3472_CR10","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-024-49259-0","volume":"15","author":"MR Fazazi","year":"2024","unstructured":"Fazazi MR, Doss P, Pereira R, Fudge N, Regmi A, Joly-Beauparlant C, Akbar I, Yeola AP, Mailhot B, Baillargeon J, et al. Myelin-reactive B cells exacerbate CD4(+) T cell-driven CNS autoimmunity in an IL-23-dependent manner. Nat Commun. 2024;15:5404.","journal-title":"Nat Commun"},{"key":"3472_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fimmu.2012.00281","volume":"3","author":"Y Wang","year":"2012","unstructured":"Wang Y, Rothstein TL. Induction of Th17 cell differentiation by B-1 cells. Front Immunol. 2012;3:281.","journal-title":"Front Immunol"},{"key":"3472_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s00415-021-10744-x","volume":"269","author":"M Margoni","year":"2022","unstructured":"Margoni M, Preziosa P, Filippi M, Rocca MA. Anti-CD20 therapies for multiple sclerosis: current status and future perspectives. J Neurol. 2022;269:1316\u201334.","journal-title":"J Neurol"},{"key":"3472_CR13","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118:3420\u201330.","journal-title":"J Clin Invest"},{"key":"3472_CR14","doi-asserted-by":"publisher","first-page":"188696","DOI":"10.1016\/j.bbcan.2022.188696","volume":"1877","author":"X Huang","year":"2022","unstructured":"Huang X, Zhang G, Tang T, Gao X, Liang T. One shoot, three birds: targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment. Biochim Biophys Acta Rev Cancer. 2022;1877:188696.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3472_CR15","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1038\/sj.onc.1205711","volume":"21","author":"AM Fry","year":"2002","unstructured":"Fry AM. The Nek2 protein kinase: a novel regulator of centrosome structure. Oncogene. 2002;21:6184\u201394.","journal-title":"Oncogene"},{"key":"3472_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2005.06.017","volume":"237","author":"DG Hayward","year":"2006","unstructured":"Hayward DG, Fry AM. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 2006;237:155\u201366.","journal-title":"Cancer Lett"},{"key":"3472_CR17","doi-asserted-by":"publisher","first-page":"677763","DOI":"10.3389\/fonc.2021.677763","volume":"11","author":"L Zhou","year":"2021","unstructured":"Zhou L, Ding L, Gong Y, Zhao J, Zhang J, Mao Z, Wang Z, Zhang W, Zhou R. NEK2 promotes cell proliferation and Glycolysis by regulating PKM2 abundance via phosphorylation in diffuse large B-Cell lymphoma. Front Oncol. 2021;11:677763.","journal-title":"Front Oncol"},{"key":"3472_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2012.12.001","volume":"23","author":"W Zhou","year":"2013","unstructured":"Zhou W, Yang Y, Xia J, Wang H, Salama ME, Xiong W, Xu H, Shetty S, Chen T, Zeng Z, et al. NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers. Cancer Cell. 2013;23:48\u201362.","journal-title":"Cancer Cell"},{"key":"3472_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-017-0392-4","volume":"10","author":"Z Gu","year":"2017","unstructured":"Gu Z, Xia J, Xu H, Frech I, Tricot G, Zhan F. NEK2 promotes aerobic Glycolysis in multiple myeloma through regulating splicing of pyruvate kinase. J Hematol Oncol. 2017;10:17.","journal-title":"J Hematol Oncol"},{"key":"3472_CR20","doi-asserted-by":"publisher","first-page":"621082","DOI":"10.1155\/2014\/621082","volume":"2014","author":"Z Gu","year":"2014","unstructured":"Gu Z, Zhou W, Huang J, Yang Y, Wendlandt E, Xu H, He X, Tricot G, Zhan F. Nek2 is a novel regulator of B cell development and immunological response. Biomed Res Int. 2014;2014:621082.","journal-title":"Biomed Res Int"},{"key":"3472_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/cns.13831","volume":"28","author":"ST Wu","year":"2022","unstructured":"Wu ST, Han JR, Yao N, Li YL, Zhang F, Shi Y, Shi FD, Li ZG. Activation of P2X4 receptor exacerbates acute brain injury after intracerebral hemorrhage. CNS Neurosci Ther. 2022;28:1008\u201318.","journal-title":"CNS Neurosci Ther"},{"key":"3472_CR22","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.1158\/0008-5472.CAN-08-1915","volume":"68","author":"G Wu","year":"2008","unstructured":"Wu G, Qiu XL, Zhou L, Zhu J, Chamberlin R, Lau J, Chen PL, Lee WH. Small molecule targeting the Hec1\/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal. Cancer Res. 2008;68:8393\u20139.","journal-title":"Cancer Res"},{"key":"3472_CR23","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.cell.2022.05.020","volume":"185","author":"K Shi","year":"2022","unstructured":"Shi K, Li H, Chang T, He W, Kong Y, Qi C, Li R, Huang H, Zhu Z, Zheng P, et al. Bone marrow hematopoiesis drives multiple sclerosis progression. Cell. 2022;185:2234\u2013e22472217.","journal-title":"Cell"},{"key":"3472_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41593-018-0100-x","volume":"21","author":"B Ajami","year":"2018","unstructured":"Ajami B, Samusik N, Wieghofer P, Ho PP, Crotti A, Bjornson Z, Prinz M, Fantl WJ, Nolan GP, Steinman L. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat Neurosci. 2018;21:541\u201351.","journal-title":"Nat Neurosci"},{"key":"3472_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","volume":"11","author":"D Schafflick","year":"2020","unstructured":"Schafflick D, Xu CA, Hartlehnert M, Cole M, Schulte-Mecklenbeck A, Lautwein T, Wolbert J, Heming M, Meuth SG, Kuhlmann T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247.","journal-title":"Nat Commun"},{"key":"3472_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12974-022-02667-9","volume":"19","author":"F Straeten","year":"2022","unstructured":"Straeten F, Zhu J, B\u00f6rsch AL, Zhang B, Li K, Lu IN, Gross C, Heming M, Li X, Rubin R, et al. Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-na\u00efve multiple sclerosis. J Neuroinflammation. 2022;19:306.","journal-title":"J Neuroinflammation"},{"key":"3472_CR27","doi-asserted-by":"crossref","unstructured":"Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, Sundar PD, Telman D, Zhao LZ, Derstine M et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med 2014, 6.","DOI":"10.1126\/scitranslmed.3008930"},{"key":"3472_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, et al. Memory B cells activate Brain-Homing, autoreactive CD4\u2009+\u2009T cells in multiple sclerosis. Cell. 2018;175:85\u2013e100123.","journal-title":"Cell"},{"key":"3472_CR29","doi-asserted-by":"crossref","unstructured":"DiSano KD, Gilli F, Pachner AR. Memory B cells in multiple sclerosis: emerging players in disease pathogenesis. Front Immunol 2021, 12.","DOI":"10.3389\/fimmu.2021.676686"},{"key":"3472_CR30","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and immunotherapy. Neuron. 2018;97:742\u201368.","journal-title":"Neuron"},{"key":"3472_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear receptor RORgammat directs the differentiation program of Proinflammatory IL-17\u2009+\u2009T helper cells. Cell. 2006;126:1121\u201333.","journal-title":"Cell"},{"key":"3472_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967\u201374.","journal-title":"Nat Immunol"},{"key":"3472_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","volume":"17","author":"MT Cencioni","year":"2021","unstructured":"Cencioni MT, Mattoscio M, Magliozzi R, Bar-Or A, Muraro PA. B cells in multiple sclerosis \u2014 from targeted depletion to immune reconstitution therapies. Nat Reviews Neurol. 2021;17:399\u2013414.","journal-title":"Nat Reviews Neurol"},{"key":"3472_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41419-022-04512-6","volume":"13","author":"J Xiang","year":"2022","unstructured":"Xiang J, Alafate W, Wu W, Wang Y, Li X, Xie W, Bai X, Li R, Wang M, Wang J. NEK2 enhances malignancies of glioblastoma via NIK\/NF-\u03baB pathway. Cell Death Dis. 2022;13:58.","journal-title":"Cell Death Dis"},{"key":"3472_CR35","doi-asserted-by":"crossref","unstructured":"Dana D, Das T, Choi A, Bhuiyan AI, Das TK, Talele TT, Pathak SK. Nek2 kinase signaling in malaria, bone, immune and kidney disorders to metastatic cancers and drug resistance: progress on Nek2 inhibitor development. Molecules 2022, 27.","DOI":"10.3390\/molecules27020347"},{"key":"3472_CR36","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI98765","volume":"128","author":"R Franqui-Machin","year":"2018","unstructured":"Franqui-Machin R, Hao M, Bai H, Gu Z, Zhan X, Habelhah H, Jethava Y, Qiu L, Frech I, Tricot G, Zhan F. Destabilizing NEK2 overcomes resistance to proteasome Inhibition in multiple myeloma. J Clin Invest. 2018;128:2877\u201393.","journal-title":"J Clin Invest"},{"key":"3472_CR37","doi-asserted-by":"crossref","unstructured":"Zhang X, Huang X, Xu J, Li E, Lao M, Tang T, Zhang G, Guo C, Zhang X, Chen W et al. NEK2 Inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nat Commun 2021, 12.","DOI":"10.1038\/s41467-021-24769-3"},{"key":"3472_CR38","doi-asserted-by":"crossref","unstructured":"Gu Z, Xia J, Xu H, Frech I, Tricot G, Zhan F. NEK2 promotes aerobic Glycolysis in multiple myeloma through regulating splicing of pyruvate kinase. J Hematol Oncol 2017, 10.","DOI":"10.1186\/s13045-017-0392-4"},{"key":"3472_CR39","doi-asserted-by":"crossref","unstructured":"Zhou L, Ding L, Gong Y, Zhao J, Zhang J, Mao Z, Wang Z, Zhang W, Zhou R. NEK2 promotes cell proliferation and Glycolysis by regulating PKM2 abundance via phosphorylation in diffuse large B-Cell lymphoma. Front Oncol 2021, 11.","DOI":"10.3389\/fonc.2021.677763"},{"key":"3472_CR40","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.xcrm.2023.101214","volume":"4","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Guo W, Cao H, Zhu Y, Ashby C, Bauer MA, et al. High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma. Cell Rep Med. 2023;4:101214.","journal-title":"Cell Rep Med"},{"key":"3472_CR41","doi-asserted-by":"publisher","first-page":"101237","DOI":"10.1016\/j.xcrm.2023.101237","volume":"4","author":"C Lischer","year":"2023","unstructured":"Lischer C, Bruns H. Breaking barriers: NEK2 Inhibition shines in multiple myeloma treatment. Cell Rep Med. 2023;4:101237.","journal-title":"Cell Rep Med"},{"key":"3472_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fimmu.2015.00636","volume":"6","author":"L Michel","year":"2015","unstructured":"Michel L, Touil H, Pikor NB, Gommerman JL, Prat A, Bar-Or A. B cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-Compartmentalized inflammation. Front Immunol. 2015;6:636.","journal-title":"Front Immunol"},{"key":"3472_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X, S\u00f8rensen PS, Hohlfeld R, Hauser SL. Role of B cells in multiple sclerosis and related disorders. Ann Neurol. 2021;89:13\u201323.","journal-title":"Ann Neurol"},{"key":"3472_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376:209\u201320.","journal-title":"N Engl J Med"},{"key":"3472_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, et al. Ocrelizumab versus interferon Beta-1a in relapsing multiple sclerosis. N Engl J Med. 2017;376:221\u201334.","journal-title":"N Engl J Med"},{"key":"3472_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-11-18","volume":"11","author":"SM Menezes","year":"2014","unstructured":"Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, L\u00f3pez G, Alvarez C, Talledo M, Gotuzzo E, et al. CD80\u2009+\u2009and CD86\u2009+\u2009B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy\/tropical spastic paraparesis and multiple sclerosis. J Neuroinflammation. 2014;11:18.","journal-title":"J Neuroinflammation"},{"key":"3472_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-510X(99)00132-X","volume":"167","author":"MT Boylan","year":"1999","unstructured":"Boylan MT, Crockard AD, McDonnell GV, Armstrong MA, Hawkins SA. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose Methylprednisolone. J Neurol Sci. 1999;167:79\u201389.","journal-title":"J Neurol Sci"},{"key":"3472_CR48","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1172\/JCI119455","volume":"99","author":"K Gen\u00e7","year":"1997","unstructured":"Gen\u00e7 K, Dona DL, Reder AT. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest. 1997;99:2664\u201371.","journal-title":"J Clin Invest"},{"key":"3472_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-022-02411-w","volume":"143","author":"R Li","year":"2022","unstructured":"Li R, Tang H, Burns JC, Hopkins BT, Le Coz C, Zhang B, de Barcelos IP, Romberg N, Goldstein AC, Banwell BL, et al. BTK Inhibition limits B-cell\u2013T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy. Acta Neuropathol. 2022;143:505\u201321.","journal-title":"Acta Neuropathol"},{"key":"3472_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-023-02877-9","volume":"20","author":"B Nuesslein-Hildesheim","year":"2023","unstructured":"Nuesslein-Hildesheim B, Ferrero E, Schmid C, Huck C, Smith P, Tisserand S, Rubert J, Bornancin F, Eichlisberger D, Cenni B. Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis. J Neuroinflammation. 2023;20:194.","journal-title":"J Neuroinflammation"},{"key":"3472_CR51","doi-asserted-by":"publisher","first-page":"e3895","DOI":"10.1002\/cbf.3895","volume":"42","author":"Z Darvish","year":"2024","unstructured":"Darvish Z, Kheder RK, Faraj TA, Najmaldin SK, Mollazadeh S, Nosratabadi R, Esmaeili SA. A better Understanding of the role of the CTLA-CD80\/86 axis in the treatment of autoimmune diseases. Cell Biochem Funct. 2024;42:e3895.","journal-title":"Cell Biochem Funct"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03472-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T13:09:44Z","timestamp":1749215384000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03472-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03472-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The plasma sample of participants was processed following the protocol that was approved by the institutional review board of Tianjin Medical University General Hospital (Tianjin, China) (APPROVAL NUMBER IRB2021-KY-134). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}